AJP - Endocrinology and Metabolism, Vol 273, Issue 1 E139-E148, Copyright © 1997 by American Physiological Society

ARTICLES

In vivo NMR investigation of intramuscular glucose metabolism in conscious rats

B. M. Jucker, A. J. Rennings, G. W. Cline, K. F. Petersen and G. I. Shulman
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8020, USA.

In vivo 13C nuclear magnetic resonance (NMR) spectroscopy was used to determine quantitatively the flux of muscle glycolysis, glycogen synthesis, pyruvate dehydrogenase, and pyruvate carboxylation in the hindlimb of conscious rats. 13C NMR spectroscopy was used to observe [1-13C]glucose label precursor incorporation into intramuscular [1-13C]glycogen, [3-13C]lactate, and [3-13C]alanine during a hyperglycemic (approximately 11 mM)-hyperinsulinemic (10 mU.kg-1.min-1) clamp. The glycogen synthesis rate was calculated to be 224 +/- 23 nmol.g-1.min-1. The kinetic data obtained from the label turnover in the intramuscular C-3 lactate and C-3 alanine metabolite pools, as well as in plasma C-3 lactate and C-3 alanine, were combined with a steady-state rate analysis to determine the glycolytic flux (67.4 +/- 10.1 nmol.g-1.min-1). Steady-state isotopomer analysis of glutamate and pyruvate in skeletal muscle tissue extracts was used to determine the anaplerotic contribution of substrate via pyruvate carboxylation (Vpc). The pyruvate dehydrogenase flux (Vpdh) was calculated after a steady-state flux correction for Vpc. Calculated values of Vpc and Vpdh were 24.8 +/- 4.3 and 110.0 +/- 18.7 nmol.g-1.min-1, respectively. In addition, [2-13C]acetate was used in a separate study to determine that pyruvate carboxylation was the major pathway for anaplerosis in skeletal muscle under conditions of hyperglycemia-hyperinsulinemia.

This article has been cited by other articles:

				T.-L. Yue, S. S. Nerurkar, W. Bao, B. M. Jucker, L. Sarov-Blat, K. Steplewski, E. H. Ohlstein, and R. N. Willette In Vivo Activation of Peroxisome Proliferator-Activated Receptor-{delta} Protects the Heart from Ischemia/Reperfusion Injury in Zucker Fatty Rats J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 466 - 474. [Abstract] [Full Text] [PDF]

				M. E. Walton, D. Ebert, and R. G. Haller Octanoate oxidation measured by 13C-NMR spectroscopy in rat skeletal muscle, heart, and liver J Appl Physiol, November 1, 2003; 95(5): 1908 - 1916. [Abstract] [Full Text] [PDF]

				W. Z. Martini, W. C. Stanley, H. Huang, C. D. Rosiers, C. L. Hoppel, and H. Brunengraber Quantitative assessment of anaplerosis from propionate in pig heart in vivo Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E351 - E356. [Abstract] [Full Text] [PDF]

				B. M. Jucker, T. R. Schaeffer, R. E. Haimbach, T. S. McIntosh, D. Chun, M. Mayer, D. H. Ohlstein, H. M. Davis, S. A. Smith, A. R. Cobitz, et al. Normalization of Skeletal Muscle Glycogen Synthesis and Glycolysis in Rosiglitazone-Treated Zucker Fatty Rats: An In Vivo Nuclear Magnetic Resonance Study Diabetes, July 1, 2002; 51(7): 2066 - 2073. [Abstract] [Full Text] [PDF]

				R. Gruetter, E. R. Seaquist, and K. Ugurbil A mathematical model of compartmentalized neurotransmitter metabolism in the human brain Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E100 - E112. [Abstract] [Full Text] [PDF]

				P. H. McNulty, G. W. Cline, J. M. Whiting, and G. I. Shulman Regulation of myocardial [13C]glucose metabolism in conscious rats Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H375 - H381. [Abstract] [Full Text] [PDF]

				B. M. Jucker, N. Barucci, and G. I. Shulman Metabolic control analysis of insulin-stimulated glucose disposal in rat skeletal muscle Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E505 - E512. [Abstract] [Full Text] [PDF]

				G. W. Cline, B. M. Jucker, Z. Trajanoski, A. J. M. Rennings, and G. I. Shulman A novel 13C NMR method to assess intracellular glucose concentration in muscle, in vivo Am J Physiol Endocrinol Metab, February 1, 1998; 274(2): E381 - E389. [Abstract] [Full Text] [PDF]